GlassScriptPhysician profile
Vincent Milazzo
NPI 1144292749
$385.79
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $219 · 2021: $62.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $128.99 | 2019-2020 | |
| Silk Road Medical, INC. | $50.13 | 2021 | |
| Endologix LLC | $48.24 | 2020 | |
| Medtronic Vascular, INC. | $32.06 | 2020 | |
| Janssen Pharmaceuticals, INC | $30.38 | 2020 | |
| Abbott Laboratories | $20.09 | 2019 | |
| Angiodynamics, INC. | $17.40 | 2019 | |
| Smith+Nephew, INC. | $17.36 | 2019 | |
| Misonix INC | $14.73 | 2020 | |
| Cardinal Health 200 LLC | $14.40 | 2020 | |
| Medtronic, INC. | $12.01 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Milazzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.